刘甜甜，医学博士，副教授。
联系方式：liu.tiantian@sdu.edu.cn
教育和工作经历
2003–2009，山东大学医学院临床医学六年制，学士
2009–2010，山东大学医学院病原生物学专业，硕士
2010–2014，瑞典卡罗林斯卡医学院，博士
2014–2021，山东大学基础医学院病理学系，助理研究员
2021–至今，山东大学基础医学院病理学系，副教授
主要研究方向
肿瘤的基因学改变及表达调控
主持的课题
1. 山东省自然科学基金面上项目，ZR201911130482，m6A RNA甲基化对端粒稳态的调节及其在衰老和肿瘤中的作用，2020-01-2022-12
2. 山东大学-瑞典卡罗林斯卡医学院合作科研基金，2019-01-2019-12
3. 国家自然科学基金青年基金，81502409，端粒酶逆转录酶(ＴＥＲＴ) 和β-Catenin异常变化及其相互作用对肝癌发生/肝癌干细胞特性的影响，2016-01-2018-12
4. 山东大学青年学者未来计划，2016-07-2021-06
讲授的课程
病理学、人体结构与功能、研究生、留学生课程。
代表性论文
1. Jing Hao, Tiantian Liu*, Yuchen Xiu , Huiyang Yuan and Dawei Xu* High DNA methylation age deceleration defines an aggressive phenotype with immunoexclusion environments in endometrial carcinoma Frontiers in immunology.10.3389/fimmuy. 2023,1208223
2. Tiantian Liu 1,*, Jiansheng Wang 1 , Yuchen Xiu 1 , Yujiao Wu 2 and Dawei Xu, DNA Methylation Age Drift Is Associated with Poor Outcomes and De-Differentiation in Papillary and Follicular Thyroid Carcinomas. Cancers,2021,10.3390/cancers13194827
3. Jingya Yu, #*, Xiaotian Yuana, Louise Sjöholm, Tiantian Liu,*, Feng Kong, Tomas J. Ekström, Magnus Björkholm, Dawei Xu，Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma. CANCER LETTERS, 2018 Oct 10;434:33-41. doi: 10.1016/j.canlet.2018.07.013.
4. Liu Tiantian#; Wang Na#; Cao Jia; Sofiadis Anastasios; Dinets, Andrii; Zedenius, Jan; Larsson, Catharina*; Xu, Dawei*, The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas., Oncogene, 2014. 33(42), pp 4978-4984
5. Liu, Tiantian; Liang, Xiuming; Li, Bingnan; Bjorkholm, Magnus; Jia, Jihui*; Xu, Dawei*, Telomerase reverse transcriptase inhibition stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celecoxib to exert anti-cancer effects., British Journal of Cancer, 2013 108(11), pp 2272-2280
6. Na Wang#, Tiantian Liu#, Anastasios Sofiadis, C. Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson*, Dawei Xu*, The TERT promoter mutation as an early genetic event in follicular thyroid carcinogenesis. 2014 Cancer, 120(19), pp 2965-2979
7. Liu, Tiantian#; Brown, Taylor C#; Juhlin, C Christofer*; Andreasson, Adam; Wang, Na; Backdahl, Martin; Healy, James M; Prasad, Manju L; Korah, Reju; Carling, Tobias; Xu, Dawei; Larsson, Catharina, The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors., Endocrine-Related Cancer, 2014 21(3), pp 427-434
